Naomi Sacks, PhD

Block 2S-Z
Written By Guest User

VICE PRESIDENT
Pharmaceutical Commercialization

My specialty is in developing and disseminating evidence that advances access for emerging therapies. I bring over 30 years in health economics and outcomes research, data analytics, and therapy commercialization to projects that quantify product value for multiple stakeholders. I work across therapeutic areas, including rare and ultra rare, neglected, and prevalent indications. As a partner, I work collaboratively with clients to develop and implement robust solutions that address their strategic needs.

Guest User
Previous

Tim Robison, PhD, DABT
Next

Rachel Sawyer